SCHEMBL22013643

SCHEMBL22013643

Nc1ccnc2ccc(N3CCCC3)nc12

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 18/20 0.61
HTR3A P46098 1/20 0.43
CXCR4 P61073 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22013645 0.82 MAP4K4 (0.55) MAP4K4CXCR4
SCHEMBL22013226 0.81 MAP4K4 (0.54) MAP4K4CXCR4
SCHEMBL23836983 0.81 MAP4K4 (0.54) MAP4K4
SCHEMBL22013122 0.80 MAP4K4 (0.53) MAP4K4
SCHEMBL23836955 0.80 MAP4K4 (0.53) MAP4K4
SCHEMBL22013653 0.78 MAP4K4 (0.51) MAP4K4
SCHEMBL23837044 0.77 MAP4K4 (0.50) MAP4K4HTR3ACXCR4
SCHEMBL23837030 0.77 MAP4K4 (0.50) MAP4K4
SCHEMBL15537122 0.76 MAP4K4 (1.00) MAP4K4
SCHEMBL22013250 0.72 MAP4K4 (0.45) MAP4K4CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882247-A1 SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-09-22 EP disclosed
WO-2020098723-A1 SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR 上海轶诺药业有限公司 2020-05-22 WO disclosed